While the appreciation of the Chinese renminbi has stalled over the past week or so, we think that it will make further headway against the US dollar over the coming months.
Amongst the financial market fallout from last week’s news about progress towards a vaccine against COVID-19, one of the more interesting but less remarked upon effects was a ~1% fall in the renminbi against the dollar. And, while the impact of today’s news that a second vaccine has also proven effective in stage three trials has been much more limited, the renminbi fell back a touch in offshore trading on that announcement too.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services